Open AccessImmunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
Author(s) -
Paul Zarogoulidis,
Kosmas Tsakiridis,
Qiang Li,
Karapanzos,
Ziogas,
Xatzizisi,
Boutsikou,
Darwiche,
Kyriazis,
Theodoros Kontakiotis,
Κonstantinos Porpodis,
Latsios
Publication year - 2013
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s43184
Subject(s) - chemotherapy , lung cancer , medicine , oncology , cancer , phases of clinical research
To evaluate the effect of immunotherapy on response, survival, and certain immune markers in patients with small cell lung cancer (SCLC) who are receiving chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom